863328-18-1

Basic information

• Product Name: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-benzo[d]imidazol-2-amine
• Synonyms: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-benzo[d]imidazol-2-amine
• CAS NO: 863328-18-1
• Molecular Weight: 259.116
• Mol File: 863328-18-1.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 466.3±37.0 °C(Predicted)
• Density: 1.20±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-benzo[d]imidazol-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-benzo[d]imidazol-2-amine(863328-18-1)
• EPA Substance Registry System: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-benzo[d]imidazol-2-amine(863328-18-1)

Safety Data

• Hazardous Substances Data: 863328-18-1(Hazardous Substances Data)

Upstream product

• 833486-94-5 4-amino-3-nitrophenylboronic acid pinacol ester 
• 506-68-3 bromocyane 
• 73183-34-3 bis(pinacol)diborane 
• 851883-08-4 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzene-1,2-diamine 
• 875-51-4 4-Bromo-2-nitroaniline 

Relevant articles and documents

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

Disclosed herein are kinase inhibitor compounds having the structure (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, X, L, Q, and Y are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.

METALLO-BETA-LACTAMASE INHIBITORS

The present invention relates to compounds of formula I that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.